nach oben

Acta Neurologica Belgica

Erschienen in:

29.09.2022 | Original article

Effects of LSVT-BIG via telerehabilitation on non-motor and motor symptoms and quality of life in Parkinson’s disease

verfasst von: Yasemin Ekmekyapar Fırat, Türkan Turgay, Selver Seval Soğan, Pınar Günel Karadeniz

Erschienen in: Acta Neurologica Belgica | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Parkinson’s disease (PD) is a neurodegenerative disease with motor and non-motor symptoms affecting the quality of life. This study aimed to investigate the effects of the Lee Silverman Voice Therapy (LSVT)-BIG rehabilitation program via telerehabilitation on quality of life, motor and non-motor symptoms in people with Parkinson’s disease (PwPD), and their correlation with each other.

Methods

Fifteen patients with mild-to-moderate PD (Hoehn and Yahr stages 1–3) were included in the LSVT-BIG exercise program with remote access for 16 sessions over four weeks. Motor and non-motor experiences before and after the program were evaluated with MDS-UPDRS parts 1, 2, and 3 and quality of life with PDQ-39. The correlation between MDS-UPDRS parts and PDQ-39 subgroups was examined.

Results

Following the application of the LSVT-BIG rehabilitation program with remote access, MDS-UPDRS parts 1, 2, and 3 scores and PDQ-39 summary index (PDQ-39 SI) and subgroup scores (excluding social support) were improved. A moderate–strong correlation was determined between MDS-UPDRS parts 1 and 2 and the PDQ-39 parameters of the patients.

Conclusion

Both motor and non-motor symptoms may be associated with the quality of life in PD. We have concluded that LSVT-BIG treatment via telerehabilitation can improve motor and non-motor symptoms along with the quality of life in PwPD.

Pringsheim T, Jette N, Frolkis A, Steeves TDL (2014) The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29:1583–1590. https://doi.org/10.1002/mds.25945CrossRefPubMed

Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601. https://doi.org/10.1002/mds.26424CrossRefPubMed

Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24:1641–1649. https://doi.org/10.1002/mds.22643CrossRefPubMed

Zhao N, Yang Y, Zhang L et al (2021) Quality of life in Parkinson’s disease: a systematic review and meta-analysis of comparative studies. CNS Neurosci Ther 27:270–279. https://doi.org/10.1111/cns.13549CrossRefPubMed

Garg D, Dhamija R (2020) Rehabilitation in Parkinson’s disease: current status and future directions. Ann Mov Disord 3:79–85. https://doi.org/10.4103/AOMD.AOMD_1_20CrossRef

McDonnell MN, Rischbieth B, Schammer TT, Seaforth C, Shaw AJPA (2018) Lee Silverman voice treatment (LSVT)-BIG to improve motor function in people with Parkinson’s disease: a systematic review and meta-analysis. Clin Rehabil 32:607–618CrossRefPubMed

Flood MW, O’Callaghan BPF, Diamond P et al (2020) Quantitative clinical assessment of motor function during and following LSVT-BIG® therapy. J Neuroeng Rehabil 17:1–19. https://doi.org/10.1186/s12984-020-00729-8CrossRef

Schaible F, Maier F, Buchwitz TM et al (2021) Effects of Lee Silverman voice treatment BIG and conventional physiotherapy on non-motor and motor symptoms in Parkinson’s disease: a randomized controlled study comparing three exercise models. Ther Adv Neurol Disord 14:1–18. https://doi.org/10.1177/1756286420986744CrossRef

Dashtipour K, Johnson E, Kani C et al (2015) (2015) Effect of exercise on motor and nonmotor symptoms of Parkinson’s disease. Parkinsons Dis 58637:1–5. https://doi.org/10.1155/2015/586378CrossRef

10.

Maresca G, Maggio MG, De Luca R et al (2020) Tele-neuro-rehabilitation in Italy: state of the art and future perspectives. Front Neurol 11:1–12. https://doi.org/10.3389/fneur.2020.563375CrossRef

11.

Winters JM (2002) Telerehabilitation research: emerging opportunities. Annu Rev Biomed Eng 4:287–320. https://doi.org/10.1146/annurev.bioeng.4.112801.121923CrossRefPubMed

12.

Seron P, Oliveros MJ, Gutierrez-Arias R et al (2021) Effectiveness of telerehabilitation in physical therapy: a rapid overview. Phys Ther 101:1–18. https://doi.org/10.1093/ptj/pzab053CrossRef

13.

Werneke MW, Deutscher D, Grigsby D et al (2021) Telerehabilitation during the COVID-19 pandemic in outpatient rehabilitation settings: a descriptive study. Phys Ther 101:1–11. https://doi.org/10.1093/ptj/pzab110CrossRef

14.

Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184. https://doi.org/10.1136/jnnp.55.3.181CrossRefPubMedPubMedCentral

15.

Hoehn MM, Yahr MD (1967) Parkinsonism : onset, progression, and mortality. Neurology 17:427–442CrossRefPubMed

16.

Fox C, Ebersbach G, Ramig L (2012) Sapir S (2012) LSVT LOUD and LSVT BIG: behavioral treatment programs for speech and body movement in Parkinson disease. Parkinsons Dis 39194:1–12. https://doi.org/10.1155/2012/391946CrossRef

17.

Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and Well Being for Individuals with Parkinson ’ s Disease Linked references are available on JSTOR for this article : the development and validation of a short measure of functioning and wel. Qual Life Res 4:241–248CrossRefPubMed

18.

Kayapinar T (2018) Parkinson Hastalığı Yaşam Kalitesi Anketi (Pdq-39) Güvenirlik Ve Geçerlik Çalışması. masterThesis 10204801:1–106

19.

Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement disorder society-sponsored revision of the unified Parkinson’s Disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170. https://doi.org/10.1002/mds.22340CrossRefPubMed

20.

Akbostanci MC, Bayram E, Yilmaz V et al (2018) Turkish standardization of movement disorders society unified Parkinson’s disease rating scale and unified dyskinesia rating scale. Mov Disord Clin Pract 5:54–59. https://doi.org/10.1002/mdc3.12556CrossRefPubMed

21.

Ebersbach G, Grust U, Ebersbach A et al (2015) Amplitude-oriented exercise in Parkinson’s disease: a randomized study comparing LSVT-BIG and a short training protocol. J Neural Transm 122:253–256. https://doi.org/10.1007/s00702-014-1245-8CrossRefPubMed

22.

Iwai M, Koyama S, Takeda K et al (2021) Effect of LSVT® BIG on standing balance in a Parkinson’s patient: a case report. Physiother Res Int 26:1–8. https://doi.org/10.1002/pri.1921CrossRef

23.

Fishel SC, Hotchkiss ME, Brown SA (2020) The impact of LSVT BIG therapy on postural control for individuals with Parkinson disease: a case series. Physiother Theory Pract 36:834–843. https://doi.org/10.1080/09593985.2018.1508260CrossRefPubMed

24.

Tomlinson CL, Herd CP, Clarke CE, Meek C, Patel S, Stowe R, Deane KHO, Shah L, Sackley CM, Wheatley KIN (2007) Physiotherapy for Parkinson ’ s disease : a comparison of techniques ( Review ). Cochrane Collab. https://doi.org/10.1002/14651858.CD002815.pub2.www.cochranelibrary.comCrossRef

25.

Fox SH, Katzenschlager R, Lim SY et al (2018) International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson’s disease. Mov Disord 33:1248–1266. https://doi.org/10.1002/mds.27372CrossRefPubMed

26.

Millage B, Vesey E, Finkelstein M, Anheluk M (2017) Effect on gait speed, balance, motor symptom rating, and quality of life in those with stage I Parkinson’s disease utilizing LSVT BIG®. Rehabil Res Pract 2017:1–8. https://doi.org/10.1155/2017/9871070CrossRef

27.

Fleming Walsh S, Balster C, Chandler A et al (2022) LSVT BIG® and long-term retention of functional gains in individuals with Parkinson’s disease. Physiother Theory Pract 38:629–636. https://doi.org/10.1080/09593985.2020.1780655CrossRefPubMed

28.

Pappala K, Garuda B, Seepana G et al (2019) Non-motor symptoms of Parkinson’s disease: Its prevalence across various stages and its correlation with the severity of the disease and quality of life. Ann Mov Disord 2:102–108. https://doi.org/10.4103/AOMD.AOMD_9_19CrossRef

29.

Barboza NM, Terra MB, Bueno MEB et al (2019) Physiotherapy versus physiotherapy plus cognitive training on cognition and quality of life in parkinson disease: randomized clinical trial. Am J Phys Med Rehabil 98:460–468. https://doi.org/10.1097/PHM.0000000000001128CrossRefPubMed

30.

Cusso ME, Donald KJ, Khoo TK (2016) The impact of physical activity on non-motor symptoms in Parkinson’s disease: a systematic review. Front Med 3:1–9. https://doi.org/10.3389/fmed.2016.00035CrossRef

31.

Nadeau A, Pourcher E, Corbeil P (2014) Effects of 24 wk of treadmill training on gait performance in parkinson’s disease. Med Sci Sports Exerc 46:645–655. https://doi.org/10.1249/MSS.0000000000000144CrossRefPubMed

32.

Duncan RP, Earhart GM (2012) Randomized controlled trial of community-based dancing to modify disease progression in Parkinson disease. Neurorehabil Neural Repair 26:132–143. https://doi.org/10.1177/1545968311421614CrossRefPubMed

33.

McNeely ME, Duncan RP, Earhart GM (2015) Impacts of dance on non-motor symptoms, participation, and quality of life in Parkinson disease and healthy older adults. Maturitas 82:336–341. https://doi.org/10.1016/j.maturitas.2015.08.002CrossRefPubMedPubMedCentral

34.

Ellis T, Boudreau JK, Deangelis TR et al (2013) Barriers to exercise in people with Parkinson disease. Phys Ther 93:628–636CrossRefPubMedPubMedCentral

35.

Villegas IL, Israel V (2014) Effect of the ai-chi method on functional activity, quality of life, and posture in patients with parkinson disease. Top Geriatr Rehabil 30:282–289. https://doi.org/10.1097/TGR.0000000000000039CrossRef

36.

Terrens AF, Soh SE, Morgan P (2021) Perceptions of aquatic physiotherapy and health-related quality of life among people with Parkinson’s disease. Heal Expect. https://doi.org/10.1111/hex.13202CrossRef

37.

Herman T, Giladi N, Gruendlinger LHJ (2007) Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson’s disease: a pilot study. Arch Phys Med Rehabil 88:1154–1158CrossRefPubMed

38.

Peterka M, Odorfer T, Schwab M et al (2020) LSVT-BIG therapy in Parkinson’s disease: physiological evidence for proprioceptive recalibration. BMC Neurol 20:1–8. https://doi.org/10.1186/s12883-020-01858-2CrossRef

39.

Ebersbach G, Ebersbach A, Edler D et al (2010) Comparing exercise in Parkinson’s disease - The Berlin LSVT®BIG study. Mov Disord 25:1902–1908. https://doi.org/10.1002/mds.23212CrossRefPubMed

40.

Martínez-Martín P, Rodríguez-Blázquez C, Forjaz MJ et al (2014) Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson’s disease patients. Eur J Neurol 21:519–524. https://doi.org/10.1111/ene.12349CrossRefPubMed

41.

Ellis T, Cavanaugh JT, Earhart GM et al (2011) Which measures of physical function and motor impairment best predict quality of life in Parkinson’s disease? Park Relat Disord 17:693–697. https://doi.org/10.1016/j.parkreldis.2011.07.004CrossRef

42.

Kadastik-Eerme L, Rosenthal M, Paju T et al (2015) Health-related quality of life in Parkinson’s disease: a cross-sectional study focusing on non-motor symptoms. Health Qual Life Outcomes 13:1–8. https://doi.org/10.1186/s12955-015-0281-xCrossRef

43.

Skorvanek M, Rosenberger J, Minar M et al (2015) Relationship between the non-motor items of the MDS-UPDRS and quality of life in patients with Parkinson’s disease. J Neurol Sci 353:87–91. https://doi.org/10.1016/j.jns.2015.04.013CrossRefPubMed

44.

Ueno T, Kon T, Haga R et al (2020) Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson’s disease: a retrospective observational cohort study. Neurol Sci 41:2867–2873. https://doi.org/10.1007/s10072-020-04406-5CrossRefPubMed

45.

Erro R, Picillo M, Vitale C et al (2016) The non-motor side of the honeymoon period of Parkinson ’ s disease and its relationship with quality of life : a 4-year longitudinal study. Eur J Neurol. https://doi.org/10.1111/ene.13106CrossRefPubMed

46.

Prakash KM, Nadkarni NV, Lye W et al (2016) The impact of non-motor symptoms on the quality of life of Parkinson ’ s disease patients : a longitudinal study. Eur J Neurol. https://doi.org/10.1111/ene.12950CrossRefPubMed

47.

Ogawa M, Oyama G, Sekimoto S et al (2022) Current status of telemedicine for Parkinson’s disease in Japan: a single-center cross-sectional questionnaire survey. J Mov Disord 15:58–61. https://doi.org/10.14802/jmd.21096CrossRefPubMed

48.

Garg D, Majumdar R, Chauhan S et al (2021) Teleneurorehabilitation among person with parkinson’s disease in India: the initial experience and barriers to implementation. Ann Indian Acad Neurol 24:536–541. https://doi.org/10.4103/aian.AIAN_127_21CrossRefPubMedPubMedCentral

49.

Lei C, Sunzi K, Dai F et al (2019) Effects of virtual reality rehabilitation training on gait and balance in patients with Parkinson’s disease: a systematic review. PLoS One 14:1–17. https://doi.org/10.1371/journal.pone.0224819CrossRef

50.

Canning CG, Allen NE (2020) Virtual reality in research and rehabilitation of gait and balance in Parkinson disease. Nat Rev Neurol 16:409–425. https://doi.org/10.1038/s41582-020-0370-2CrossRefPubMed

Titel: Effects of LSVT-BIG via telerehabilitation on non-motor and motor symptoms and quality of life in Parkinson’s disease
verfasst von: Yasemin Ekmekyapar Fırat
Türkan Turgay
Selver Seval Soğan
Pınar Günel Karadeniz
Publikationsdatum: 29.09.2022
Verlag: Springer International Publishing
Erschienen in: Acta Neurologica Belgica / Ausgabe 1/2023
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI: https://doi.org/10.1007/s13760-022-02104-x

Myasthenia gravis with amyotrophic lateral sclerosis with positive anti-Hu antibody: a rare co-existence

Letter to the Editor

Bilateral hypoplasia of the internal carotid artery

Letter to the Editor

Sneddon syndrome: a rare cause of stroke hidden in plain sight

Letter to the Editor

Hyperbaric oxygen therapy in carbon monoxide poisoning in Moroccan patients

Original article

Temporal lobe epilepsy with nocturnal wandering leading to discovery of Moyamoya Angiopathy

Letter to the Editor

Role of the anterior choroidal artery in the endovascular treatment of brain arteriovenous malformations

Review article

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Ein pulverisierter Plastiklöffel im Gehirn

07.02.2025
Umweltmedizin
Nachrichten

Das menschliche Gehirn besteht zu etwa 0,5% aus Nanoplastik – Tendenz weiter steigend. Nach Resultaten eine Autopsiestudie reichert sich Plastik im Gehirn 10- bis 30-fach stärker an als in anderen Organen – mit bislang noch völlig unklaren Folgen.

Schlaganfall durch wandernde A. carotis interna

07.02.2025
Ischämischer Schlaganfall
Nachrichten

Die Thrombolyse nützte nichts, vielmehr war eine Teilresektion des Zungenbeins nötig: Es hatte eine verlagerte Carotis interna komprimiert und so bei einem älteren Mann einen Schlaganfall ausgelöst. Per Bildgebung lässt sich eine solche Ursache manchmal nur schwer nachweisen.

Epileptischer Anfall nach Darmreinigung

05.02.2025
Hyponatriämie
Nachrichten

Die Darmreinigung vor einer Koloskopie führte einen älteren Mann auf die Intensivstation: Seine Natriumwerte waren durch die Prozedur so gesunken, dass er Bewusstseinstrübungen und Krampfanfälle entwickelte.

Welche Faktoren das Demenzrisiko bei Vorhofflimmern beeinflussen

05.02.2025
Vorhofflimmern
Nachrichten

In einer Metaanalyse wurden elf Faktoren identifiziert, die bei Vorhofflimmern(VHF)-Patienten mit dem Risiko für eine kognitive Beeinträchtigung assoziiert sind. Im besten Fall eröffnet sich damit ein Weg für die Prävention.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Effects of LSVT-BIG via telerehabilitation on non-motor and motor symptoms and quality of life in Parkinson’s disease